{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:10:05Z","timestamp":1774743005222,"version":"3.50.1"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"Introduction<\/jats:title>Candida albicans<\/jats:italic> is the primary cause of systemic candidiasis, which is involved in high morbidity and mortality. Drug resistance exacerbates these problems. In addition, there are limited antifungal drugs available. In order to solve these problems, combination therapy has aroused great interest. Teriflunomide is an immunosuppressant. In the present work, we aimed to identify whether teriflunomide can reverse the resistance of Candida albicans<\/jats:italic> in the presence of sub-inhibitory concentrations of fluconazole in vitro<\/jats:italic> and in vivo<\/jats:italic>.<\/jats:p><\/jats:sec>Methods<\/jats:title>Seven Candida albicans<\/jats:italic> isolates were used in this study. Susceptibility of Candida albicans in vitro<\/jats:italic> to the drugs was determined using a checkerboard microdilution assay in accordance with the recommendations of the Clinical and Laboratory Standards Institute. The effects of drugs on biofilm biomass of Candida albicans<\/jats:italic> were determined by crystal violet staining. The development ability of Candida albicans<\/jats:italic> hyphae was performed using a modified broth microdilution method. Galleria mellonella<\/jats:italic> was used for testing the in vivo<\/jats:italic> efficacy of the combination therapies. <\/jats:p><\/jats:sec>Results<\/jats:title>We found that the combination of teriflunomide (64 \u00b5g\/mL) and fluconazole (0.5-1 \u00b5g\/mL) has a significant synergistic effect in all resistant Candida albicans<\/jats:italic> isolates (n=4). Also, this drug combination could inhibit the immature biofilm biomass and hyphae formation of resistant Candida albicans<\/jats:italic>. Galleria mellonella<\/jats:italic> was used for testing the in vivo efficacy of this combination therapies. As for the Galleria mellonella<\/jats:italic> larvae infected by resistant Candida albicans<\/jats:italic>, teriflunomide (1.6 \u00b5g\/larvae) combined with fluconazole (1.6 \u00b5g\/larvae) significantly increased their survival rates, and reduced the fungal burden, as well as damage of tissue in comparison to that in the control group or drug monotherapy group. <\/jats:p><\/jats:sec>Conclusion<\/jats:title>These results expand our knowledge about the antifungal potential of teriflunomide as an adjuvant of existing antifungal drugs, and also open new perspectives in the treatment of resistant Candida albicans<\/jats:italic> based on repurposing clinically available nonantifungal drugs.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2023.1282320","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T08:56:00Z","timestamp":1702976160000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Synergistic potential of teriflunomide with fluconazole against resistant Candida albicans in vitro and in vivo"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiuyun","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqiong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenghua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shicun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145053","article-title":"Synergistic Interactions of Eugenol-tosylate and Its Congeners with Fluconazole against Candida albicans","volume":"10","author":"Ahmad","year":"2015","journal-title":"PloS One"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/vetsci10080513","article-title":"Comparative evaluation of GS-441524, teriflunomide, ruxolitinib, molnupiravir, ritonavir, and nirmatrelvir for in vitro antiviral activity against feline infectious peritonitis virus","volume":"10","author":"Barua","year":"2023","journal-title":"Vet. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/femsre\/fuv035","article-title":"Fungal dimorphism: the switch from hyphae to yeast is a specialized morphogenetic adaptation allowing colonization of a host","volume":"39","author":"Boyce","year":"2015","journal-title":"FEMS Microbiol. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1574-695X.2002.tb00617.x","article-title":"Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae","volume":"34","author":"Brennan","year":"2002","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041624","article-title":"Retigeric acid B attenuates the virulence of Candida albicans via inhibiting adenylyl cyclase activity targeted by enhanced farnesol production","volume":"7","author":"Chang","year":"2012","journal-title":"PloS One"},{"key":"B6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/21505594.2020.1748930","article-title":"The regulation of hyphae growth in Candida albicans","volume":"11","author":"Chen","year":"2020","journal-title":"Virulence"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17101643","article-title":"Dissecting Candida albicans infection from the perspective of C. albicans virulence and omics approaches on host-pathogen interaction: a review","volume":"17","author":"Chin","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1128\/AAC.46.12.3846-3853.2002","article-title":"In vitro activity of micafungin (FK-463) against Candida spp.: microdilution, time-kill, and postantifungal-effect studies","volume":"46","author":"Ernst","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","article-title":"Tackling the emerging threat of antifungal resistance to human health","volume":"20","author":"Fisher","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1099\/mic.0.000499","article-title":"Microbe Profile: Candida albicans: a shape-changing, opportunistic pathogenic fungus of humans","volume":"163","author":"Gow","year":"2017","journal-title":"Microbiol. (Reading)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/microorganisms8030390","article-title":"Galleria mellonella for the evaluation of antifungal efficacy against medically important fungi, a narrative review","volume":"8","author":"Jemel","year":"2020","journal-title":"Microorganisms"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s10156-013-0639-0","article-title":"Combinatory effect of fluconazole and FDA-approved drugs against Candida albicans","volume":"19","author":"Kaneko","year":"2013","journal-title":"J. Infect. Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3390\/jof4030113","article-title":"The use of Galleria mellonella larvae to identify novel antimicrobial agents against fungal species of medical interest","volume":"4","author":"Kavanagh","year":"2018","journal-title":"J. Fungi (Basel)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.drudis.2012.05.007","article-title":"Drug discovery in pharmaceutical industry: productivity challenges and trends","volume":"17","author":"Khanna","year":"2012","journal-title":"Drug Discovery Today"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1128\/AAC.46.4.1046-1052.2002","article-title":"In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry","volume":"46","author":"Kohli","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"106676","DOI":"10.1016\/j.mimet.2023.106676","article-title":"Detection of microscopic filamentous fungal biofilms - choosing the suitable methodology","volume":"205","author":"Kulisova","year":"2023","journal-title":"J. Microbiol. Methods"},{"key":"B17","doi-asserted-by":"publisher","first-page":"101395","DOI":"10.1016\/j.bbrep.2022.101395","article-title":"In vitro evaluation of the activity of teriflunomide against SARS-CoV-2 and the human coronaviruses 229E and OC43","volume":"33","author":"Lang","year":"2023","journal-title":"Biochem. Biophys. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nbt.1549","article-title":"Synergistic drug combinations tend to improve therapeutically relevant selectivity","volume":"27","author":"Lehar","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02295","article-title":"Synergistic effects and mechanisms of combined treatment with harmine hydrochloride and azoles for resistant candida albicans","volume":"10","author":"Li","year":"2019","journal-title":"Front. Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s11427-018-9830-0","article-title":"Apoptosis-linked antifungal effect of ambroxol hydrochloride by cystolic calcium concentration disturbance in resistant Candida albicans","volume":"62","author":"Li","year":"2019","journal-title":"Sci. China Life Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41598-019-57174-4","article-title":"Proton pump inhibitors act synergistically with fluconazole against resistant Candida albicans","volume":"10","author":"Lu","year":"2020","journal-title":"Sci. Rep."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00447","article-title":"Alizarin and chrysazin inhibit biofilm and hyphal formation by candida albicans","volume":"7","author":"Manoharan","year":"2017","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"153223","DOI":"10.1016\/j.phymed.2020.153223","article-title":"In vitro and in vivo effects of the combination of myricetin and miconazole nitrate incorporated to thermosensitive hydrogels, on C. albicans biofilms","volume":"71","author":"Mo","year":"2020","journal-title":"Phytomedicine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph14121587","article-title":"An alternative approach to investigate biofilm in medical devices: A feasibility study","volume":"14","author":"Petrachi","year":"2017","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ijantimicag.2019.05.016","article-title":"Aripiprazole repurposed as an inhibitor of biofilm formation and sterol biosynthesis in multidrug-resistant Candida albicans","volume":"54","author":"Rajasekharan","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B28","article-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved Standard\u2014Third Edition. CLSI document M27-A3","author":"Rex","year":"2008"},{"key":"B29","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1146\/annurev-micro-030117-020345","article-title":"Molecular evolution of antifungal drug resistance","volume":"71","author":"Robbins","year":"2017","journal-title":"Annu. Rev. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s40265-019-01135-8","article-title":"Teriflunomide: A review in relapsing-remitting multiple sclerosis","volume":"79","author":"Scott","year":"2019","journal-title":"Drugs"},{"key":"B31","doi-asserted-by":"publisher","first-page":"17070","DOI":"10.1038\/srep17070","article-title":"A combination approach to treating fungal infections","volume":"5","author":"Shrestha","year":"2015","journal-title":"Sci. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.2217\/fmb.13.101","article-title":"Mechanisms of Candida biofilm drug resistance","volume":"8","author":"Taff","year":"2013","journal-title":"Future Microbiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1439-0507.2011.02076.x","article-title":"Antifungal susceptibility of Candida albicans in biofilms","volume":"55","author":"Tobudic","year":"2012","journal-title":"Mycoses"},{"key":"B34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3855\/jidc.11102","article-title":"Enhancement of antimicrobial activity of pump inhibitors associating drugs","volume":"13","author":"Usai","year":"2019","journal-title":"J. Infect. Dev. Ctries"},{"key":"B35","doi-asserted-by":"publisher","first-page":"S328","DOI":"10.1093\/mmy\/myz012","article-title":"Antifungal drugs: What brings the future","volume":"57","author":"Van Daele","year":"2019","journal-title":"Med. Mycol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0155814","DOI":"10.1371\/journal.pone.0155814","article-title":"Characterization and functional analysis of 4-coumarate:CoA ligase genes in mul-berry","volume":"11","author":"Wang","year":"2016","journal-title":"PloS One"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1517\/17425255.2013.800483","article-title":"Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis","volume":"9","author":"Wiese","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.drudis.2014.06.009","article-title":"In pursuit of the ideal antifungal agent for Candida infections: high-throughput screening of small molecules","volume":"19","author":"Wong","year":"2014","journal-title":"Drug Discovery Today"},{"key":"B39","doi-asserted-by":"publisher","first-page":"105804","DOI":"10.1016\/j.ijantimicag.2019.09.008","article-title":"Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence","volume":"55","author":"Zhang","year":"2020","journal-title":"Int. J. Antimicrob. Agents"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1282320\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T08:56:10Z","timestamp":1702976170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1282320\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":39,"alternative-id":["10.3389\/fcimb.2023.1282320"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2023.1282320","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,19]]},"article-number":"1282320"}}